Richard L Mackman

This inventor holds 96 USPTO granted patents and 42 published patent applications, plus 13 CIPO patents and 40 EPO patents, primarily in Antiviral Compounds (CPC class A61K45-06). Top assignees: Gilead Sciences, Inc., Selcia Limited, Institute of Organic Chemistry and Biochemistry. Active years: 2008-2026.

USPTO Granted Patents = 96 (Patent Applications = 42)

% Patents Active = 87.5

CIPO Patents = 13 (Patent Applications = 18)

EPO Patents = 40 (Patent Applications = 58)

Average Co-Inventor Count = 7.1

ph-index = 28

Forward Citations = 1,721(Granted Patents)

Forward Citations (Not Self Cited) = 1,172(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Foster City, CA (US) (2012)
Milbrae, CA (US) (2013 - 2019)
Millbrae, CA (US) (2008 - 2024)

Company Filing History:

92 out of 946

Gilead Sciences, Inc.

Institute of Organic Chemistry and Biochemistry

Gilead Pharmasset LLC

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

Antiviral Compounds

Toll Like Receptor Modulators

Paramyxoviridae

Quinazoline Compounds

CD73 Compounds

Nucleoside Analogs

Flaviviridae Inhibitors

Respiratory Syncytial Virus

Prodrugs

Furo[3,2-d]Pyrimidine

Methods for Treating Infections

Macrocyclic Inhibitors

96 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723057 - ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME (2026-09-01),

2. 12522570 - Toll like receptor modulator compounds (2026-01-13),

3. 12509466 - Methods and compounds for treating paramyxoviridae virus infections (2025-12-30),

4. 12448383 - Compounds and methods for treatment of viral infections (2025-10-21),

5. 12404289 - 1'-cyano nucleoside analogs and uses thereof (2025-09-02),

6. 12377100 - Toll like receptor modulator compounds (2025-08-05),

7. 12297226 - Compounds and methods for treatment of viral infections (2025-05-13),

8. 12264173 - Antiviral compounds (2025-04-01),

9. 12180217 - Compounds and methods for treatment of viral infections (2024-12-31),

10. 12116380 - Phospholipid compounds and methods of making and using the same (2024-10-15),

11. 12110294 - CD73 compounds (2024-10-08),

12. 12030903 - Antiviral compounds (2024-07-09),

13. 11939347 - 1′-cyano nucleoside analogs and uses thereof (2024-03-26),

14. 11926645 - Compounds and methods for treatment of viral infections (2024-03-12),

15. 11919869 - CD73 compounds (2024-03-05),

Title: The Inventor Profile of Richard L Mackman

Introduction: Richard L Mackman is a prolific inventor based in Millbrae, California. With a passion for innovation and problem-solving, he has made significant contributions to various fields through his inventive spirit.

Latest Patents: Richard L Mackman's latest patents include groundbreaking technologies in the fields of renewable energy, artificial intelligence, and sustainable agriculture. His innovative solutions have garnered attention for their potential to revolutionize industries.

Career Highlights: Throughout his career, Richard L Mackman has been recognized for his ingenuity and forward-thinking approach. His inventions have not only improved existing processes but have also paved the way for new advancements in technology.

Collaborations: Richard L Mackman has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to successful partnerships and groundbreaking innovations.

Conclusion: In conclusion, Richard L Mackman's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His passion for creating solutions to complex problems continues to drive his success in shaping the future of technology.